Skip to main content
. 2017 Feb;184:97–105. doi: 10.1016/j.ahj.2016.10.020

Table I.

Summary statistics, before multiple imputations of the missing data, of baseline and procedural characteristics in the UK TAVI dataset

Variable Summary (% of n = 6676) Missing (% of n = 6676)
Age, mean [range] 81.3 [29–101] 0 (0%)
Women, n (%) 3085 (46.2%) 22 (0.3%)
Weight (kg), mean [range] 74.0 [32.0–190.0] 131 (2.0%)
Height (m), mean [range] 1.6 [1.1–2.4] 159 (2.4%)
NYHA 42 (0.6%)
 Class I, n (%) 185 (2.8%)
 Class II, n (%) 1116 (16.7%)
 Class III, n (%) 4186 (62.7%)
 Class IV, n (%) 1147 (17.2%)
Creatinine, μmol/L, mean [range] 114.3 [29.0–1044.0] 73 (1.1%)
Creatinine greater than 200 μmol/L, n (%) 379 (5.7%) 73 (1.1%)
LVEF 59 (0.88%)
 ≥50%, n (%) 4074 (61.0%)
 30–49%, n (%) 1929 (28.9%)
 <30%, n (%) 614 (9.2%)
Extracardiac arteriopathy, n (%) 1572 (23.5%) 88 (1.3%)
Diabetes 35 (0.52%)
 Dietary control, n (%) 290 (4.3%)
 Oral medicine, n (%) 884 (13.2%)
 Insulin, n (%) 363 (5.4%)
Dialysis, n (%) 127 (1.9%) 66 (0.99%)
MI 33 (0.49%)
 Within 90 days of TAVI, n (%) 153 (2.3%)
 Within 30 days of TAVI, n (%) 65 (0.97%)
 Within 24 hours of TAVI, n (%) 6 (0.09%)
Procedure urgency 7 (0.10%)
 Elective, n (%) 5853 (87.7%)
 Urgent, n (%) 772 (11.6%)
 Emergency, n (%) 35 (0.52%)
 Salvage, n (%) 9 (0.13%)
Valve type 31 (0.46%)
 Edwards SAPIEN Valve, n (%) 3684 (55.2%)
 Medtronic CoreValve, n (%) 2735 (41.0%)
Access route 13 (0.19%)
 TF access, n (%) 4965 (74.4%)
 Transapical access, n (%) 1064 (15.9%)
Chronic lung disease, n (%) 1879 (28.1%) 94 (1.4%)
Cerebrovascular disease, n (%) 1139 (17.1%) 35 (0.52%)
Previous cardiac surgery, n (%) 2087 (31.3%) 35 (0.52%)
Critical preoperative state, n (%) 110 (1.6%) 81 (1.2%)
PA systolic >60 mmHg 785 (11.8) 1860 (27.9%)
LMS >50% or Triple vessel disease, n (%) 887 (13.3%) 74 (1.1%)

LMS, Left main stem disease; MI, myocardial infarction; NYHA, New York Heart Association Functional Classification; PA, pulmonary artery; TF, transfemoral access route.